- Home
- PRM vs TVTX Comparison
PRM vs TVTX Comparison
Compare PRM & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRM
- TVTX
- Stock Information
- Founded
- PRM 2018
- TVTX 2008
- Country
- PRM United States
- TVTX United States
- Employees
- PRM N/A
- TVTX N/A
- Industry
- PRM Newspapers/Magazines
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PRM Consumer Discretionary
- TVTX Health Care
- Exchange
- PRM Nasdaq
- TVTX Nasdaq
- Market Cap
- PRM 1.5B
- TVTX 1.4B
- IPO Year
- PRM N/A
- TVTX N/A
- Fundamental
- Price
- PRM $14.08
- TVTX $14.69
- Analyst Decision
- PRM Strong Buy
- TVTX Strong Buy
- Analyst Count
- PRM 2
- TVTX 16
- Target Price
- PRM $15.50
- TVTX $33.33
- AVG Volume (30 Days)
- PRM 1.0M
- TVTX 1.5M
- Earning Date
- PRM 07-31-2025
- TVTX 07-31-2025
- Dividend Yield
- PRM N/A
- TVTX N/A
- EPS Growth
- PRM N/A
- TVTX N/A
- EPS
- PRM 0.90
- TVTX N/A
- Revenue
- PRM $573,954,000.00
- TVTX $273,533,000.00
- Revenue This Year
- PRM N/A
- TVTX $73.84
- Revenue Next Year
- PRM $5.12
- TVTX $46.72
- P/E Ratio
- PRM $15.67
- TVTX N/A
- Revenue Growth
- PRM 70.16
- TVTX 75.65
- 52 Week Low
- PRM $7.49
- TVTX $7.72
- 52 Week High
- PRM $14.44
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- PRM 73.32
- TVTX 43.19
- Support Level
- PRM $13.74
- TVTX $14.56
- Resistance Level
- PRM $14.30
- TVTX $15.27
- Average True Range (ATR)
- PRM 0.39
- TVTX 0.67
- MACD
- PRM 0.00
- TVTX 0.15
- Stochastic Oscillator
- PRM 82.07
- TVTX 50.00
About PRM Perimeter Solutions SA
Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The Company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the Company's retardant and foam products. The Specialty Products segment includes operations that develop, produce and market products for non-fire safety markets. Specialty Products segment is Phosphorus Pentasulfide (P2S5) based lubricant additives. P2S5 is also used in pesticide and mining chemicals applications, and emerging electric battery technologies.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.